Published in Gastroenterology on October 01, 2001
Guidelines on the irritable bowel syndrome: mechanisms and practical management. Gut (2007) 3.87
Evidence-based clinical practice guidelines for irritable bowel syndrome. J Gastroenterol (2014) 2.30
The epidemiology of irritable bowel syndrome. Clin Epidemiol (2014) 2.06
Early life risk factors that contribute to irritable bowel syndrome in adults: a systematic review. Am J Gastroenterol (2008) 1.85
Irritable bowel syndrome in twins: genes and environment. Gut (2006) 1.81
Association between a functional polymorphism in the serotonin transporter gene and diarrhoea predominant irritable bowel syndrome in women. Gut (2004) 1.55
Investigation of esophageal sensation and biomechanical properties in functional chest pain. Neurogastroenterol Motil (2010) 1.44
Genetic variation in the beta-2 adrenergic receptor (ADRB2) predicts functional gastrointestinal diagnoses and poorer health-related quality of life. Aliment Pharmacol Ther (2013) 1.42
Sodium channel mutation in irritable bowel syndrome: evidence for an ion channelopathy. Am J Physiol Gastrointest Liver Physiol (2008) 1.33
Familial aggregation of irritable bowel syndrome: a prospective study. Gut (2003) 1.33
Irritable bowel syndrome: diagnosis and pathogenesis. World J Gastroenterol (2012) 1.32
Biopsychosocial model of irritable bowel syndrome. J Neurogastroenterol Motil (2011) 1.25
Irritable bowel syndrome aggregates strongly in families: a family-based case-control study. Neurogastroenterol Motil (2008) 1.19
Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Genetic epidemiology and pharmacogenetics in irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol (2012) 1.19
Genetic approaches to functional gastrointestinal disorders. Gastroenterology (2010) 1.18
The place of antibiotics in management of irritable bowel syndrome: a systematic review and meta-analysis. Arch Med Sci (2010) 1.10
Irritable bowel syndrome: a clinical review. World J Gastroenterol (2014) 1.10
The role of genetics in IBS. Gastroenterol Clin North Am (2011) 1.07
An Update on Post-infectious Irritable Bowel Syndrome: Role of Genetics, Immune Activation, Serotonin and Altered Microbiome. J Neurogastroenterol Motil (2012) 1.07
Epidemiology of Functional Gastrointestinal Disorders in Japan and in the World. J Neurogastroenterol Motil (2015) 1.04
Is irritable bowel syndrome an organic disorder? World J Gastroenterol (2014) 1.01
Changing face of irritable bowel syndrome. World J Gastroenterol (2006) 0.99
Familial aggregation of irritable bowel syndrome: a family case-control study. Am J Gastroenterol (2010) 0.99
Genetics of irritable bowel syndrome. Am J Gastroenterol (2008) 0.98
Genetic determination of irritable bowel syndrome. World J Gastroenterol (2008) 0.97
Genetic contributions to pain: a review of findings in humans. Oral Dis (2008) 0.96
A cross-sectional study of the association between overnight call and irritable bowel syndrome in medical students. Can J Gastroenterol (2012) 0.95
Psychosocial factors at work and in every day life are associated with irritable bowel syndrome. Eur J Epidemiol (2007) 0.94
Underlying molecular and cellular mechanisms in childhood irritable bowel syndrome. Mol Cell Pediatr (2016) 0.94
Current insights in to the pathophysiology of Irritable Bowel Syndrome. Gut Pathog (2010) 0.94
Updates on treatment of irritable bowel syndrome. World J Gastroenterol (2008) 0.94
Irritable bowel syndrome: the evolution of multi-dimensional looking and multidisciplinary treatments. World J Gastroenterol (2014) 0.89
Exploring the intergenerational transmission of illness behavior: from observations to experimental intervention. Ann Behav Med (2011) 0.88
Probiotics and irritable bowel syndrome. World J Gastroenterol (2013) 0.88
Social learning contributions to the etiology and treatment of functional abdominal pain and inflammatory bowel disease in children and adults. World J Gastroenterol (2007) 0.87
IBS--review and what's new. MedGenMed (2006) 0.87
The role of 5-HTT LPR and GNβ3 825C>T polymorphisms and gene-environment interactions in irritable bowel syndrome (IBS). Dig Dis Sci (2012) 0.87
Family history of irritable bowel syndrome is the major determinant of persistent abdominal complaints in young adults with a history of pediatric recurrent abdominal pain. World J Gastroenterol (2006) 0.87
Genetics and irritable bowel syndrome: from genomics to intermediate phenotype and pharmacogenetics. Dig Dis Sci (2009) 0.87
Is health care seeking for irritable bowel syndrome and functional dyspepsia a socially learned response to illness? Dig Dis Sci (2005) 0.87
Irritable bowel syndrome. BMJ Clin Evid (2012) 0.87
Genetic variation in neuroendocrine genes associates with somatic symptoms in the general population: results from the EPIFUND study. J Psychosom Res (2010) 0.86
Interaction between ingested nutrients and gut endocrine cells in patients with irritable bowel syndrome (review). Int J Mol Med (2014) 0.85
Genes and environment in irritable bowel syndrome: one step forward. Gut (2006) 0.84
Sexual orientation and functional pain in U.S. young adults: the mediating role of childhood abuse. PLoS One (2013) 0.84
Recent developments in the pathophysiology of irritable bowel syndrome. World J Gastroenterol (2015) 0.84
Protocol for a randomized controlled study of Iyengar yoga for youth with irritable bowel syndrome. Trials (2011) 0.83
IBS: An epigenetic perspective. Nat Rev Gastroenterol Hepatol (2010) 0.83
Individual and additive effects of mothers' and fathers' chronic pain on health outcomes in young adults with a childhood history of functional abdominal pain. J Pediatr Psychol (2013) 0.82
Patients treated by tegaserod for irritable bowel syndrome with constipation showed significant improvement in fibromyalgia symptoms. A pilot study. Clin Rheumatol (2009) 0.82
Genes and irritable bowel syndrome: is there a link? Curr Gastroenterol Rep (2008) 0.82
Association of interleukin-10 polymorphisms with risk of irritable bowel syndrome: a meta-analysis. World J Gastroenterol (2013) 0.82
Psychosocial mechanisms for the transmission of somatic symptoms from parents to children. World J Gastroenterol (2015) 0.81
The importance of relationships in patients with irritable bowel syndrome: a review. Gastroenterol Res Pract (2011) 0.80
Treatment of irritable bowel syndrome: beyond fiber and antispasmodic agents. Therap Adv Gastroenterol (2011) 0.80
Functional abdominal pain in childhood: background studies and recent research trends. Pain Res Manag (2012) 0.80
Irritable bowel syndrome in children: pathogenesis, diagnosis and evidence-based treatment. World J Gastroenterol (2014) 0.80
Co-occurrence of IBS and symptoms of anxiety or depression, among Norwegian twins, is influenced by both heredity and intrauterine growth. BMC Gastroenterol (2015) 0.79
Genetic epidemiology of irritable bowel syndrome. World J Gastroenterol (2015) 0.79
Relationship between serotonin transporter gene polymorphism and constipation in cancer patients. Contemp Oncol (Pozn) (2015) 0.78
Irritable bowel syndrome: a review article. Middle East J Dig Dis (2010) 0.78
Enhanced auditory brainstem response and parental bonding style in children with gastrointestinal symptoms. PLoS One (2012) 0.78
Leu72Met408 Polymorphism of the Ghrelin Gene Is Associated With Early Phase of Gastric Emptying in the Patients With Functional Dyspepsia in Japan. J Neurogastroenterol Motil (2015) 0.78
Development and validation of new disease-specific measures of somatization and comorbidity in IBS. J Psychosom Res (2012) 0.78
Challenges and prospects for pharmacotherapy in functional gastrointestinal disorders. Therap Adv Gastroenterol (2010) 0.78
Family history of mental illness or alcohol abuse and the irritable bowel syndrome. J Psychosom Res (2014) 0.78
Irritable bowel syndrome. BMJ Clin Evid (2010) 0.77
Nitric oxide synthase gene polymorphisms in functional dyspepsia. Dig Dis Sci (2013) 0.77
The psyche and the gut. World J Gastroenterol (2007) 0.77
New and emerging therapies for the treatment of irritable bowel syndrome: an update for gastroenterologists. Therap Adv Gastroenterol (2016) 0.76
Infection and irritability. Gut (2002) 0.75
Lack of familial aggregation in chronic constipation excluding irritable bowel syndrome: a population-based study. Dig Dis Sci (2014) 0.75
Regulation of the serotonin transporter in the pathogenesis of irritable bowel syndrome. World J Gastroenterol (2016) 0.75
Evidence of overlapping genetic diathesis of panic attacks and gastrointestinal disorders in a sample of male twin pairs. Twin Res Hum Genet (2011) 0.75
Irritable Bowel Syndrome: A gut microbiota-related disorder? Am J Physiol Gastrointest Liver Physiol (2016) 0.75
Altering the gastrointestinal flora in patients with functional bowel disorders: a way ahead? Therap Adv Gastroenterol (2009) 0.75
Managing Chronic Pain in Special Populations with Emphasis on Pediatric, Geriatric, and Drug Abuser Populations. Med Clin North Am (2016) 0.75
Use of rifaximin in gastrointestinal and liver diseases. World J Gastroenterol (2016) 0.75
Identifying and testing candidate genetic polymorphisms in irritable bowel syndrome: association with TNFSF15 and tumor necrosis factor-α Ann Gastroenterol (2013) 0.75
Neuropeptide s receptor induces neuropeptide expression and associates with intermediate phenotypes of functional gastrointestinal disorders (gastroenterology 2010;138:98-107). J Neurogastroenterol Motil (2010) 0.75
Use of the Biphasic (13)C-Sucrose/Glucose Breath Test to Assess Sucrose Maldigestion in Adults with Functional Bowel Disorders. Biomed Res Int (2016) 0.75
The association between GP consultations for non-specific physical symptoms in children and parents: a case-control study. PLoS One (2014) 0.75
Irritable bowel syndrome and functional dyspepsia: different diseases or a single disorder with different manifestations? MedGenMed (2005) 0.75
Post-Infectious Irritable Bowel Syndrome. Curr Gastroenterol Rep (2017) 0.75
A multiple plasmid-containing Escherichia coli strain: convenient source of size reference plasmid molecules. Plasmid (1978) 16.08
Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology (1997) 8.51
U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci (1993) 7.98
Novel shuttle plasmid vehicles for Escherichia-Streptococcus transgeneric cloning. Gene (1983) 5.30
A cloning vector able to replicate in Escherichia coli and Streptococcus sanguis. Gene (1982) 5.13
Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group. N Engl J Med (1998) 4.66
Treatment of irritable bowel syndrome with Chinese herbal medicine: a randomized controlled trial. JAMA (1998) 4.62
A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis. N Engl J Med (1995) 4.30
The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut (2008) 3.92
Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis. Gut (2008) 3.81
A population-based twin study in women of smoking initiation and nicotine dependence. Psychol Med (1999) 3.78
Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults. Arch Intern Med (2001) 3.68
Chimeric streptococcal plasmids and their use as molecular cloning vehicles in Streptococcus sanguis (Challis). J Bacteriol (1980) 3.34
A new questionnaire for gastroesophageal reflux disease. Mayo Clin Proc (1994) 3.14
Transferable lincosamide-macrolide resistance in Bacteroides. Plasmid (1979) 3.06
Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis. Am J Gastroenterol (1999) 3.01
Initial endoscopy or empirical therapy with or without testing for Helicobacter pylori for dyspepsia: a decision analysis. Gastroenterology (1996) 3.00
The brain--gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study. Gut (2012) 2.96
Further validation of the IBS-QOL: a disease-specific quality-of-life questionnaire. Am J Gastroenterol (2000) 2.95
Risk factors for irritable bowel syndrome: role of analgesics and food sensitivities. Am J Gastroenterol (2000) 2.89
Diagnostic utility of alarm features for colorectal cancer: systematic review and meta-analysis. Gut (2008) 2.82
Sexual and physical abuse and gastrointestinal illness. Review and recommendations. Ann Intern Med (1995) 2.78
Risk factors associated with symptoms of gastroesophageal reflux. Am J Med (1999) 2.75
The outcome of patients with oesophageal eosinophilic infiltration after an eight-week trial of a proton pump inhibitor. Aliment Pharmacol Ther (2013) 2.73
Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trials. Am J Gastroenterol (1996) 2.73
The irritable bowel syndrome: long-term prognosis and the physician-patient interaction. Ann Intern Med (1995) 2.73
Irritable bowel syndrome: a technical review for practice guideline development. Gastroenterology (1997) 2.71
Review article: Associations between Helicobacter pylori and obesity--an ecological study. Aliment Pharmacol Ther (2014) 2.69
Risk of developing colorectal cancer and benign colorectal neoplasm in patients with chronic constipation. Aliment Pharmacol Ther (2014) 2.67
Prevalence of Helicobacter pylori in specific forms of gastritis. Further evidence supporting a pathogenic role for H. pylori in chronic nonspecific gastritis. Dig Dis Sci (1991) 2.67
The trkB tyrosine protein kinase is a receptor for brain-derived neurotrophic factor and neurotrophin-3. Cell (1991) 2.56
Irritable bowel syndrome: physiological and psychological differences between diarrhea-predominant and constipation-predominant patients. Dig Dis Sci (1980) 2.53
Menetrier's disease: a form of hypertrophic gastropathy or gastritis? Gastroenterology (1993) 2.52
Simple method for demonstrating small plasmid deoxyribonucleic acid molecules in oral streptococci. Appl Environ Microbiol (1980) 2.50
Severe sensory and sympathetic deficits in mice lacking neurotrophin-3. Nature (1994) 2.45
Learned illness behavior in patients with irritable bowel syndrome and peptic ulcer. Dig Dis Sci (1982) 2.43
Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection. J Gastroenterol Hepatol (1998) 2.38
Functional dyspepsia: the economic impact to patients. Aliment Pharmacol Ther (2013) 2.36
Systemic review: the prevalence and clinical course of functional dyspepsia. Aliment Pharmacol Ther (2004) 2.35
Cost-effectiveness of cimetidine maintenance therapy in chronic gastric and duodenal ulcer. Gastroenterology (1990) 2.32
Oesophageal narrowing is common and frequently under-appreciated at endoscopy in patients with oesophageal eosinophilia. Aliment Pharmacol Ther (2014) 2.30
Development and validation of a patient-assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index. Aliment Pharmacol Ther (2003) 2.28
A comparison of the Rome and Manning criteria for case identification in epidemiological investigations of irritable bowel syndrome. Am J Gastroenterol (2000) 2.27
Quality of Life in Reflux and Dyspepsia patients. Psychometric documentation of a new disease-specific questionnaire (QOLRAD). Eur J Surg Suppl (1998) 2.26
Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease. Am J Gastroenterol (2001) 2.23
Core outcomes measures for inguinal hernia repair. J Am Coll Surg (1997) 2.17
Differentiation of functional constipation and constipation predominant irritable bowel syndrome based on Rome III criteria: a population-based study. Aliment Pharmacol Ther (2015) 2.17
Spatial shaping of cochlear innervation by temporally regulated neurotrophin expression. J Neurosci (2001) 2.16
Irritable bowel syndrome prevalence varies enormously depending on the employed diagnostic criteria: comparison of Rome II versus previous criteria in a general population. Scand J Gastroenterol (2001) 2.12
Costs of health care for irritable bowel syndrome, chronic constipation, functional diarrhoea and functional abdominal pain. Aliment Pharmacol Ther (2007) 2.09
Intergenerational transmission of gastrointestinal illness behavior. Am J Gastroenterol (2000) 2.06
AGA technical review on anorectal testing techniques. Gastroenterology (1999) 2.05
The overlap of atopy and functional gastrointestinal disorders among 23,471 patients in primary care. Aliment Pharmacol Ther (2014) 2.05
The association between non-ulcer dyspepsia and other gastrointestinal disorders. Scand J Gastroenterol (1985) 2.01
Psychosocial aspects of the functional gastrointestinal disorders. Gut (1999) 1.99
The trk tyrosine protein kinase mediates the mitogenic properties of nerve growth factor and neurotrophin-3. Cell (1991) 1.97
Disseminated tetracycline resistance in oral streptococci: implication of a conjugative transposon. Infect Immun (1984) 1.96
Evidence of a genetic contribution to functional bowel disorder. Am J Gastroenterol (1998) 1.96
What determines severity among patients with painful functional bowel disorders? Am J Gastroenterol (2000) 1.91
Apoptosis in gastric epithelium induced by Helicobacter pylori infection: implications in gastric carcinogenesis. Am J Gastroenterol (2001) 1.85
Natural history of gastroesophageal reflux disease and functional abdominal disorders: a population-based study. Am J Gastroenterol (2001) 1.84
Non-cardiac chest pain: prevalence, risk factors, impact and consulting--a population-based study. Aliment Pharmacol Ther (2003) 1.84
Genetic transformation of Streptococcus sanguis (Challis) with cryptic plasmids from Streptococcus ferus. Infect Immun (1980) 1.82
Mortality rates in patients with Barrett's oesophagus. Aliment Pharmacol Ther (2007) 1.81
Learning deficits in forebrain-restricted brain-derived neurotrophic factor mutant mice. Neuroscience (2003) 1.80
Diagnostic yield of alarm features in irritable bowel syndrome and functional dyspepsia. Gut (2004) 1.76
Development and psychometric evaluation of the patient assessment of upper gastrointestinal symptom severity index (PAGI-SYM) in patients with upper gastrointestinal disorders. Qual Life Res (2004) 1.76
The mechanism of an immature secretion phenotype of a highly frequent naturally occurring missense mutation at codon 97 of human hepatitis B virus core antigen. J Virol (1999) 1.76
Short segment Barrett's oesophagus: prevalence, diagnosis and associations. Gut (1997) 1.75
The effects of lottery incentive and length of questionnaire on health survey response rates: a randomized study. J Clin Epidemiol (1999) 1.73
Differences in gastric mechanosensory function after repeated ramp distensions in non-consulters with dyspepsia and healthy controls. Gut (2000) 1.70
Association of anxiety, neuroticism, and depression with dyspepsia of unknown cause. A case-control study. Gastroenterology (1986) 1.69
Clinical predictors of small intestinal bacterial overgrowth by duodenal aspirate culture. Aliment Pharmacol Ther (2011) 1.68
Development and validation of the Diabetes Bowel Symptom Questionnaire. Aliment Pharmacol Ther (2003) 1.68
Genetic models for the analysis of data from the families of identical twins. Genetics (1976) 1.67
Familial association in adults with functional gastrointestinal disorders. Mayo Clin Proc (2000) 1.64
A biomarker panel and psychological morbidity differentiates the irritable bowel syndrome from health and provides novel pathophysiological leads. Aliment Pharmacol Ther (2014) 1.64
The role of acid suppression in patients with endoscopy-negative reflux disease: the effect of treatment with esomeprazole or omeprazole. Aliment Pharmacol Ther (2004) 1.64
Non-cardiac chest pain: squeezing the life out of the Australian healthcare system? Med J Aust (2000) 1.63
Allergic fungal sinusitis: CT findings. Radiology (1998) 1.61
Differences in patient characteristics between Veterans Administration and community hospitals. Implications for VA planning. Med Care (1987) 1.60
Symptom evaluation in reflux disease: workshop background, processes, terminology, recommendations, and discussion outputs. Gut (2004) 1.60
Eosinophil infiltration and degranulation in normal human tissue. Anat Rec (1998) 1.59
Gastroscopy is incomplete without biopsy: clinical relevance of distinguishing gastropathy from gastritis. Gastroenterology (1995) 1.59
Does Helicobacter pylori colonize the gastric mucosa of Meckel's diverticulum? Mayo Clin Proc (1990) 1.59
Histopathology of endocervical infection caused by Chlamydia trachomatis, herpes simplex virus, Trichomonas vaginalis, and Neisseria gonorrhoeae. Hum Pathol (1990) 1.58
THE ROLE OF THE QUINONE POOL IN THE CYCLIC ELECTRON-TRANSFER CHAIN OF RHODOPSEUDOMONAS SPHAEROIDES: A MODIFIED Q-CYCLE MECHANISM. Biochim Biophys Acta (1983) 1.57
A multivariate genetic analysis of the use of tobacco, alcohol, and caffeine in a population based sample of male and female twins. Drug Alcohol Depend (1999) 1.57
Overlap of gastrointestinal symptom complexes in a US community. Neurogastroenterol Motil (2005) 1.56
ABC of the upper gastrointestingal tract: Indigestion: When is it functional? BMJ (2001) 1.56
Molecular characterization of unique deletion mutants of the streptococcal plasmid, pAM beta 1. Plasmid (1980) 1.55
Selective 5-hydroxytryptamine type 3 receptor antagonism with ondansetron as treatment for diarrhea-predominant irritable bowel syndrome: a pilot study. Mayo Clin Proc (1992) 1.53
Is there a benefit from intensified medical and psychological interventions in patients with functional dyspepsia not responding to conventional therapy? Aliment Pharmacol Ther (2007) 1.51
Visceral perception in functional gastro-intestinal disorders: disease marker or epiphenomenon? Dig Dis (1997) 1.51
Factors associated with consulting medical or non-medical practitioners for dyspepsia: an australian population-based study. Aliment Pharmacol Ther (2000) 1.51
Gastro-oesophageal reflux symptoms and health-related quality of life in the adult general population--the Kalixanda study. Aliment Pharmacol Ther (2006) 1.49
Valid symptom reporting at upper endoscopy in a random sample of the Swedish adult general population: the Kalixanda study. Scand J Gastroenterol (2004) 1.49
Functional bowel disorders in women with dysmenorrhea. Am J Gastroenterol (1994) 1.49